Literature DB >> 12498526

Pharmacologic therapy for osteoarthritis.

Steven H Goldberg1, Joan M Von Feldt, Jess H Lonner.   

Abstract

Osteoarthritis is treated with a variety of pharmacologic therapies, including acetaminophen, traditional nonsteroidal anti-inflammatory drugs, cyclo-oxygenase-2 inhibitors, intra-articular steroids, viscosupplements, glucosamine, chondroitin sulfate, capsaicin, and vitamins. In this review, we describe the clinical efficacy and side effects of these pharmaceuticals. Except for vitamins, each of these therapies is effective over the short-term when compared with placebo in controlled clinical trials. Risk-benefit analysis should be considered when prescribing these medications, as side effects are relatively common, and long-term efficacy is variable. In this review, we also examine current and future research on new medications--particularly matrix metalloproteinases and inducible nitric oxide synthase inhibitors--that may modify osteoarthritis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12498526

Source DB:  PubMed          Journal:  Am J Orthop (Belle Mead NJ)        ISSN: 1078-4519


  4 in total

Review 1.  Palliative care for end-stage heart failure.

Authors:  Sarah J Goodlin
Journal:  Curr Heart Fail Rep       Date:  2005-09

Review 2.  Osteoarthritis: histology and pathogenesis.

Authors:  Irene Sulzbacher
Journal:  Wien Med Wochenschr       Date:  2012-12-20

3.  Differential metabolic effects of glucosamine and N-acetylglucosamine in human articular chondrocytes.

Authors:  A R Shikhman; D C Brinson; J Valbracht; M K Lotz
Journal:  Osteoarthritis Cartilage       Date:  2009-03-24       Impact factor: 6.576

4.  Evaluation of β-endorphin concentration, mood, and pain intensity in men with idiopathic hip osteoarthritis treated with variable magnetic field.

Authors:  Bogdan Koczy; Tomasz Stołtny; Jarosław Pasek; Maria Leksowska-Pawliczek; Szymon Czech; Alina Ostałowska; Sławomir Kasperczyk; Monika Białkowska; Grzegorz Cieślar
Journal:  Medicine (Baltimore)       Date:  2019-07       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.